Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal bipolar neuron | 3 studies | 22% ± 5% | |
GABAergic neuron | 3 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of GDF11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3075.12 | 2642 / 2642 | 100% | 24.69 | 704 / 705 |
prostate | 100% | 1905.76 | 245 / 245 | 94% | 17.00 | 473 / 502 |
ovary | 100% | 1592.91 | 180 / 180 | 91% | 16.50 | 393 / 430 |
adrenal gland | 99% | 806.50 | 255 / 258 | 90% | 12.76 | 208 / 230 |
thymus | 100% | 1065.89 | 651 / 653 | 87% | 6.07 | 528 / 605 |
bladder | 100% | 1535.05 | 21 / 21 | 79% | 6.17 | 397 / 504 |
lung | 99% | 986.53 | 573 / 578 | 77% | 5.76 | 893 / 1155 |
skin | 84% | 698.85 | 1520 / 1809 | 89% | 20.48 | 422 / 472 |
kidney | 98% | 762.84 | 87 / 89 | 74% | 4.98 | 667 / 901 |
intestine | 98% | 1211.23 | 947 / 966 | 67% | 4.17 | 355 / 527 |
uterus | 100% | 1734.40 | 170 / 170 | 64% | 7.88 | 293 / 459 |
breast | 97% | 657.59 | 447 / 459 | 62% | 3.38 | 689 / 1118 |
stomach | 88% | 590.31 | 316 / 359 | 69% | 4.60 | 198 / 286 |
esophagus | 90% | 767.49 | 1302 / 1445 | 66% | 4.19 | 121 / 183 |
pancreas | 41% | 169.85 | 133 / 328 | 74% | 4.40 | 132 / 178 |
spleen | 100% | 1611.76 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 816.77 | 1193 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 1319.36 | 833 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 88% | 608.99 | 1181 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 19.95 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 76% | 3.57 | 22 / 29 |
tonsil | 0% | 0 | 0 / 0 | 56% | 3.66 | 25 / 45 |
muscle | 53% | 259.58 | 424 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 51% | 384.53 | 478 / 929 | 0% | 0 | 0 / 0 |
liver | 25% | 91.85 | 57 / 226 | 13% | 1.02 | 54 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007498 | Biological process | mesoderm development |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0001657 | Biological process | ureteric bud development |
GO_0032924 | Biological process | activin receptor signaling pathway |
GO_0008283 | Biological process | cell population proliferation |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0001656 | Biological process | metanephros development |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_1902870 | Biological process | negative regulation of amacrine cell differentiation |
GO_0072560 | Biological process | type B pancreatic cell maturation |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0060021 | Biological process | roof of mouth development |
GO_0001501 | Biological process | skeletal system development |
GO_0007399 | Biological process | nervous system development |
GO_0035881 | Biological process | amacrine cell differentiation |
GO_0021512 | Biological process | spinal cord anterior/posterior patterning |
GO_0005615 | Cellular component | extracellular space |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0008083 | Molecular function | growth factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | GDF11 |
Protein name | Growth differentiation factor 11 Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11) |
Synonyms | BMP11 |
Description | FUNCTION: Secreted signal that acts globally to regulate anterior/posterior axial patterning during development. May play critical roles in patterning both mesodermal and neural tissues (By similarity). It is required for proper vertebral patterning and orofacial development . Signals through activin receptors type-2, ACVR2A and ACVR2B, and activin receptors type-1, ACVR1B, ACVR1C and TGFBR1 leading to the phosphorylation of SMAD2 and SMAD3 . . |
Accessions | O95390 H0YI30 ENST00000257868.10 ENST00000546799.1 |